Cumberland Rhode Island UNITED STATES



Tedor is a customer-focused, oral solid dose CDMO with a strong track record of meeting aggressive development and commercialization timelines for small to mid-size pharma companies.  Over the past last 16 years we have helped our customers receive numerous product approvals, including 10 in the last 3 years. We attribute this success to our company-wide focus on quality, customer service and meeting timelines.  Everything we do, and how we do it, is focused on helping you to achieve your product objectives.  In short – we are small enough to care and experienced enough to deliver.

In his 30-year career as a leader and entrepreneur, Drysdale has led hundreds of biopharma business development transactions, closed 15 M&A transactions, created a $500mm startup, turned around a distressed manufacturing business, led dozens of financings, built multiple teams, has co-founded a CNS development company, developed business relationships that span the globe, has brought low cost medicines to U.S. consumers, developed pipelines of pharmaceutical products and has run both private and public companies.  Drysdale was the recipient of the 2012 Ernst & Young Entrepreneur of the Year Award, 2011 International Business Award Distinguished Honoree for Executive of the Year (Pharmaceuticals) and recognized by Pharmaceutical Executive magazine as a 2011 Emerging Leader.